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INTRODUCTION: 
Drug compliance can be defined as reliability of a 
patient in using a prescribed medication as ordered by 
the physician.
1
. The importance of this term comes into 
picture when a person suffering from a chronic ailment 
is put on long term medications. Such situations come 
for diseases like diabetes, hypertension, arthritis, 
tuberculosis etc. Diabetes Mellitus (DM), the most 
common endocrine disease in the world, is a major 
global public health issue
. 3
 As a group, patients with 
diabetes are especially prone to substantial regimen 
adherence problems
.4 
Noncompliance occurs when the 
patient forgets or neglects to take the prescribed 
dosages at recommended times or decides to 
discontinue the drug without consulting the physician
1. 
Effective and successful glucose control requires 
appropriate and timely use of medication over the entire 
period of treatment, which is often lifelong. Poor 
treatment adherence that contributes to suboptimal 
glycemic control continues to be one of the major 
barriers to effective diabetes management. Treatment 
failure is in turn associated with reduced treatment 
benefits and can have a negative financial burden on 
both individual patients and the society at large
 9, 10
. In 
fact, effective diabetes management often needs 
coordinated quality services 
11
. 
The World Health Organization has reported that as 
many as fifty percent of the patients with chronic 
diseases do not take their medications as prescribed;
2
 
Diabetes is a common but easily treatable condition and 
yet the control in the society is poor due to this major 
factor of drug compliance. Drug compliance isn’t a new 
challenge. It is mentioned by the Hippocrates many 
thousands of years ago. It’s an old issue but it’s very 
crucial. For this reason, drug compliance has been 
called the “next frontier in quality improvement” and is 
an important part of diabetes therapy outcomes. 
There are many factors which affect compliance. When 
they are listed, we will be able to suggest ways and 
measures to improve the compliance on the treatment 
aspect. 
AIM: 
This study aims to evaluate the drug compliance among 
type 2 diabetes patients and infer the factors 
determining drug compliance. 
ABSTRACT 
Diabetes is one of the most common ailments that the general population suffer in today’s world. Some are aware about their 
disturbing blood sugar levels and even understand the importance of appropriate control of the levels with the right 
medications. Some are aware and yet ignorant due to various causes. This study is aimed at evaluating the drug compliance 
among type 2 diabetes patients attending the review op of the department of Diabetology, KMCH. A study group of 100 
patients attending the review OP were enrolled in the study. The compliance was assessed with the help of their diabetic OP 
records and a pretested questionnaire was used to further dig into the possible causes for non compliance. The study is broadly 
based on two main factors leading to non-compliance-causes for patients not getting medicines regularly and causes for patients 
not taking medicines regularly. These two factors were analyzed based on gender, age, duration of diabetes, co morbid illness, 
distance etc. The results have shown that 39% of the patients were not getting the medications regularly, out of which 33.3% 
did not get it due to sheer laziness,38.5% were forgetful and other serious illness hindered 28.2% of the patients from getting 
their medications. It was found that 55% of the patients took their medications regularly. Among those who took medications 
regularly,80.3% were regular and 15.4% were not regular in getting medications. Among  those who did not take medications 
regularly,66.7% claimed to be forgetful and 46.7% were non complaint as they did not have adequate knowledge about their 
medications.33.3% of the patients did not take it regularly as it gave them a feeling of wellbeing which tempted them to skip 
doses. Based on these significant data, we will be able to suggest ways and measures to improve the compliance on the 
treatment aspect. This would increase the desired therapeutic outcome and ultimately, on a broad aspect, it will reduce national 
health costs. 
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OBJECTIVE: 
 To evaluate drug compliance among type 2 diabetic 
patients. 
 To analyze the causes and consequences of non 
compliance based on a questionnaire. 
METHOD AND MATERIALS: 
Ethical clearance was obtained from Govt. Kilpauk 
medical college ethical committee. 
Study design:Cross Sectional Study  
Study Duration: Four weeks  
Study Group: One hundred patients attending the 
review op of the department of  Dialectology, KMCH. 
Informed oral consent was obtained from the patients. 
Inclusion criteria: Patients with duration of diabetes 1-
10 years 
Exclusion criteria: 
 Patients with acute complications of diabetes 
 Duration of DM>15 years 
Basic details were collected from the patient. Here 
patients carry a book which includes the basic 
demographic data (name, age, place of residence, a 
passport size photo, duration of diabetes, weight, B.P) 
the presenting complaints ,the investigations ordered, 
the blood sugar levels checked at various intervals, 
medications prescribed and complications if any 
present. The date at which they come to refill the 
prescription is also mentioned. From these records, 
compliance was assessed. Further evaluation to find out 
the causes for non-compliance was assessed by using a 
pretested questionnaire. Leading questions were not 
asked at first, the patients were allowed to give their 
own reason for non compliance, which was noted. Then 
the common factors contributing to non compliance like 
negligence, lack of adequate knowledge, forgetfulness, 
distance from the hospital etc were enquired. The 
collected data was then analyzed based on two major 
platforms-one,if the patient got the medications 
regularly and two, if he took the medicine he got from 
the hospital. Comparison was made based on various 
factors such as distance, negligence, other co morbid 
illness, knowledge about their medications , gender, 
side effects etc.  
RESULTS: 
Among 100 patients enrolled in the study,61% got their 
medications regularly and 55% were taking their 
medications regularly.80.3% of those getting their 
medications were taking their medications regularly 
(p<0.001).The causes of non compliance were broadly 
divided into –patient related factors (age, gender, 
distance from home, dependents, serious illness), 
therapy related factors (side effects, patients’s 
knowledge, other medications)and psychological 
factors(negative attitude, laziness, disbelief etc). 
The following graph explains the distribution of the 
study group based on the questions that were put forth 
to them in the questionnaire. These questions were 
pertaining to their health profile (if associated illness 
like hypertension was present), if they were regular in 
getting/taking medications, various reasons for not 
getting/taking medications regularly etc. 
 
GRAPH 1: Distribution of study group based on questionnaire 
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The following table is a comparison of patients’ regularity in getting medications from the review OP with various 
factors. Here we can infer that forgetfulness (38.5%), laziness (33.3%)and other serious illness (28.2%) hinders patients 
from getting their medications regularly. 
TABLE 1: Comparison of patients getting medicines with various causes for not getting medicines 
 Q1.0 Patient regularly getting 
medicines 
Total P-Value 
No Yes 
N % N % N % 
Q2.1 Distance of the hospital 
from house 
< 4 km 6 15.4 11 18.0 17 17.0 0.364 
4 - 6 km 12 30.8 24 39.3 36 36.0 
> 6 km 21 53.8 26 42.6 47 47.0 
Q2.2 Dependent on others for 
coming to hospital 
No 30 76.9 44 72.1 74 74.0 0.594 
Yes 9 23.1 17 27.9 26 26.0 
Q2.3 Forgetfulness No 24 61.5 51 83.6 75 75.0 0.013 
Yes 15 38.5 10 16.4 25 25.0 
Q2.4 Laziness No 26 66.7 52 85.2 78 78.0 0.029 
Yes 13 33.3 9 14.8 22 22.0 
Q2.5 Serious illness hinders No 28 71.8 54 88.5 82 82.0 0.034 
Yes 11 28.2 7 11.5 18 18.0 
Total 39 100.0 61 100.0 100 100.0  
 
 
The below table 2 compares patients who take medications regularly with various factors. Forgetfulness again plays an 
important role in non-compliance accounting for 66.7%. Some do not take their medications because they do not have 
adequate knowledge about it (46.7%). 
TABLE 2: Comparison of patients taking medicines with various causes for not getting medicines 
 
 
 
 
 
 
 
 
 Q3.0 Patient taking medicine 
regularly 
Total P-Value 
No Yes 
N % N % N % 
Q4.1 Prescription pattern 
clear & well understood 
No 2 4.4 0 0.0 2 2.0 0.200 
 Yes 43 95.6 55 100.0 98 98.0 
Q4.2 Identification of tablets 
is easy 
No 2 4.4 2 3.6 4 4.0 0.612 
Yes 43 95.6 53 96.4 96 96.0 
Q4.3 There is side effects No 20 44.4 34 61.8 54 54.0 0.124 
Yes 11 24.4 6 10.9 17 17.0 
Sometime 14 31.1 15 27.3 29 29.0 
Q4.4 Forgetful in taking 
medicines 
No 15 33.3 42 76.4 57 57.0 <0.001 
Yes 30 66.7 13 23.6 43 43.0 
Q4.5 Patient having adequate 
knowledge about the 
treatment 
No 21 46.7 10 18.2 31 31.0 0.002 
Yes 24 53.3 45 81.8 69 69.0 
Q4.6 Feeling of well being 
makes the patient to skip few 
doses 
No 30 66.7 48 88.9 78 78.8 0.007 
Yes 15 33.3 6 11.1 21 21.2 
Total 45 100.0 54 100.0 99 100.0  
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The following graph compares the two important variables of the study-those getting medications regularly with those 
taking medications regularly. 
GRAPH: 2 Comparisons of patients getting medicines regularly with patients taking medications regularly 
 
 
Patient related factors: 
The study had 71% females and 29% males.47% were staying >6km from the hospital and 26% were dependent on 
others to get their medications from the hospital. About 18% were seriously ill which hindered them from getting 
medications. 
Picture 1: distribution of study population based on distance from hospital 
Picture 2: distribution of study population based on gender 
 
 
42.6% of the people got medication regularly in spite of staying >6km from the hospital. Among regularly getting 
medications, 72.4% were males.50.7% of females did not take regular medications. 27.9% got medications by 
depending on others. 28.2% did not get medications as they were suffering from some serious illness (p=0.034). 
GRAPH 3: Comparison of gender with patients getting and taking medicines regularly 
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Psychological factors: 
38.5% did not get regular medicines due to 
forgetfulness (p=0.013)and 33.3% due to laziness 
(p=0.029). About 66.7% did not eat their medications 
due to forgetfulness (p<0.001). 53.3% did not take 
medications in spite of having adequate knowledge 
about treatment (p=0.002).Some patients skipped doses 
when they felt better. This constituted 33.3% of those 
who did not takes medicines regularly (p=0.007). 
Therapeutic factors: 
The study group had 43% with associated 
hypertension.98% were able to understand their 
prescription well and 96% could identify their tablets 
easily.17% claimed to have experienced side effects. 
And 69% claimed to have adequate knowledge about 
their treatment. 
 
GRAPH 4: Comparison of various psychological and therapeutic factors for patients to take medicines regularly 
 
 
DISCUSSION: 
The rate of non-compliance in patients with chronic 
diseases in developed countries, on long-term treatment, 
is on the order of 50%.This could be even higher in 
developing countries (WHO)
14. 
Individuals with low 
socioeconomic status cannot access education, 
information, transportation and obtain the required 
drugs on time. This may increase patients’ difficulty to 
follow diabetes treatment
. 15, 16 (
Seligman et al. 2012; 
Drewnowski and Darmon 2005). If the patient feels that 
the cost of therapy is a financial burden, the compliance 
with therapy will definitely be threatened causing low 
adherence
 17
 (Jin et al. 2008). Since most of the patients 
in our chosen study group have similar difficulties such 
as transportation, awareness and motivation, we can 
easily relate these factors to be of utmost importance 
when it comes to both receiving and consuming the 
medications regularly. Different studies have shown 
that adherence to diabetes treatment has been highly 
varied and may range from 1.4 to 88.0%
 5, 6, 7
.We have 
concluded from our study that the main reason for non-
compliance is never the same even among the patients 
of the same age group. Some believe that just by a 
proper diet plan they can control their disorder. Some 
patients feel side effects from the prescribed 
medications might interfere with their day to day life. 
Some believe in alternate medications such as Ayurveda 
or siddha for a better cure. As such compliance towards 
prescribed medications comes down. The World Health 
Organization has categorized potential reasons for 
medication nonadherence into 5 broad groupings that 
include patient, condition, therapy, socioeconomic, and 
health system–related factors.19-33 Examples for each of 
these categories are detailed in the Table 3.  
 
Table 3: Reasons for Medication Nonadherence 
Categories of 
Nonadherence 
Examples 
Health system Poor quality of provider-patient relationship; poor communication; lack of access to healthcare; 
lack of continuity of care 
Condition Asymptomatic chronic disease (lack of physical cues); mental health disorders (eg, depression) 
Patient Physical impairments (eg, vision problems or impaired dexterity); cognitive impairment; 
psychological/behavioral; younger age; nonwhite race 
Therapy Complexity of regimen; side effects 
Socioeconomic Low literacy; higher medication costs; poor social support 
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We used a similar approach in our study by highlighting 
non-compliance due to factors that are patient-centered, 
therapy-related, or healthcare system – related.12 The 
patient-centered factors can be demographic (age, 
gender, educational level, and marital status) and 
psychological (patients’ beliefs and motivation towards 
the therapy, negative attitude , patient-prescriber 
relationship, understanding of health issues , and 
patient's knowledge).
13
 The therapy-related factors 
include route of medication, duration of treatment, 
complexity of treatment, and the side effects of the 
medicines. The factors associated with the healthcare 
system include availability, accessibility, and the 
physician. In addition, it is common for patients to 
improve their medication-taking behavior shortly before 
and after an appointment with a healthcare provider, 
which has been termed “white-coat adherence.”34 
Makaryus et al
35
 found that <50% of patients were able 
to list all of their medications, and even fewer could 
recount the purpose of their medications at hospital 
discharge, which suggests that system factors like the 
educational process at hospital discharge can impact 
medication adherence after discharge. 
Low adherence to prescribed diabetes medications 
accounts for 30% to 50% of treatment failures, leading 
to worse treatment outcomes and which cause damages 
to vital organs
8 
One study showed that while diabetic 
and cardiac patients who take medication correctly have 
a 7% death rate; for those who are non-compliant the 
death rate is 12%.  
To date, interventions targeting medication adherence 
have produced only modest success. In general, 
unimodal interventions have been less successful than 
multimodal interventions, because the reasons for 
nonadherence are often multifactorial.
36-40
 Multimodal 
interventions have shown the most promise and have 
improved both adherence and outcomes. For example, 
Piette et al
41,42
 randomized veterans with diabetes 
mellitus to an intervention that consisted of 
telemonitoring with interactive voice response 
technology and weekly nurse feedback and 
demonstrated improvements in medication adherence 
and diabetes-related symptoms, as well as a trend for 
improvement in hemoglobin A1C. Family relationships 
play an important role in diabetes management. Studies 
have shown that low levels of conflict, high levels of 
cohesion and organization, and good communication 
patterns are associated with better regimen 
adherence
.43
 Greater levels of social support, 
particularly diabetes-related support from spouses and 
other family members, are associated with better 
regimen adherence
.44
 Social support also serves to 
buffer the adverse effect of stress on diabetes 
management
.45 
from the hospital point of view efforts 
can be taken to develop proper rapport with the patient 
win his confidence and counsel him about the 
importance of his compliance. Motivation is thus the 
key here. In our study we found that highly motivated 
patients overcame their problems like distance, 
associated illness, financial constraints etc. in order to 
receive their medications from the OPD. Patients who 
are forgetful/lazy to get/take medications are mostly 
those who are either unaware about their condition or 
are ignorant. Such patients must be specifically targeted 
for proper counseling about their condition, the 
importance of taking medications that are prescribed. 
CONCLUSION: 
 Diabetes is a burden which still can be managed 
appropriately if patients and health care personnel work 
as a team to ensure drug compliance. Doctors and other 
health professionals must always monitor how 
complaint their patients are and dig out the causes of 
their non-compliance by being open to their 
apprehensions and helping them overcome it in a 
positive manner.
 
Once this is achieved control of diabetes and its 
efficient management can be implemented at various 
levels. 
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